A prospective stratified case-cohort study on statins and multiple adverse events in Japan.
PURPOSE: To assess the association between statins and diverse adverse events in Japanese population. METHODS: New users of statin who started statin after 6-month period of non-use were identified in 68 hospitals between January 2008 and July 2010. In addition to the random sample subcohort, we sel...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4014577?pdf=render |
id |
doaj-cc32605692a6492d86746a8fd604cfd6 |
---|---|
record_format |
Article |
spelling |
doaj-cc32605692a6492d86746a8fd604cfd62020-11-25T01:27:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9691910.1371/journal.pone.0096919A prospective stratified case-cohort study on statins and multiple adverse events in Japan.Nobuhiro OobaTsugumichi SatoAkira WakanaTakao OriiMasaki KitamuraAkira KokanHideaki KurataYoshihiro ShimodozonoKenichi MatsuiHiroshi YoshidaTakuhiro YamaguchiShigeru KageyamaKiyoshi KubotaPURPOSE: To assess the association between statins and diverse adverse events in Japanese population. METHODS: New users of statin who started statin after 6-month period of non-use were identified in 68 hospitals between January 2008 and July 2010. In addition to the random sample subcohort, we selected additional subcohort members to make the stratified sample subcohort have at least one patient in all subgroups stratified by each combination of statin and hospital. By abstraction from medical records, detailed information was obtained for all potential cases and pre-selected subcohort members. The event review committee consisting of 3 specialists judged whether possible cases met the definition of one of the adverse events of interest, and for adjudicated cases the committee further judged whether statin was a certain, probable or possible cause of the occurrence of the event. Adjusted for covariates including age, gender, status of "switcher", use of high daily dose and comorbidities at baseline, hazard ratio (HR) was estimated by the Cox proportional hazards model with Barlow's weighting method. Data were also analyzed by the method proposed by Breslow in 2009. RESULTS: A total of 6,877 new users of a statin were identified (median age: 66 years; males: 52%). The hazard ratios of increase in serum creatinine for atorvastatin and fluvastatin have wide confidence intervals, but both of the point estimates were around 2.5. Estimates of hazard ratios by the method of Barlow (1999) were similar to those by the method of Breslow (2009). CONCLUSIONS: Use of statin was not associated with a significant increased risk for renal, liver and muscle events. However, the hazard ratio of increase in serum creatinine tended to be high with atorvastatin and fluvastatin to require further studies.http://europepmc.org/articles/PMC4014577?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nobuhiro Ooba Tsugumichi Sato Akira Wakana Takao Orii Masaki Kitamura Akira Kokan Hideaki Kurata Yoshihiro Shimodozono Kenichi Matsui Hiroshi Yoshida Takuhiro Yamaguchi Shigeru Kageyama Kiyoshi Kubota |
spellingShingle |
Nobuhiro Ooba Tsugumichi Sato Akira Wakana Takao Orii Masaki Kitamura Akira Kokan Hideaki Kurata Yoshihiro Shimodozono Kenichi Matsui Hiroshi Yoshida Takuhiro Yamaguchi Shigeru Kageyama Kiyoshi Kubota A prospective stratified case-cohort study on statins and multiple adverse events in Japan. PLoS ONE |
author_facet |
Nobuhiro Ooba Tsugumichi Sato Akira Wakana Takao Orii Masaki Kitamura Akira Kokan Hideaki Kurata Yoshihiro Shimodozono Kenichi Matsui Hiroshi Yoshida Takuhiro Yamaguchi Shigeru Kageyama Kiyoshi Kubota |
author_sort |
Nobuhiro Ooba |
title |
A prospective stratified case-cohort study on statins and multiple adverse events in Japan. |
title_short |
A prospective stratified case-cohort study on statins and multiple adverse events in Japan. |
title_full |
A prospective stratified case-cohort study on statins and multiple adverse events in Japan. |
title_fullStr |
A prospective stratified case-cohort study on statins and multiple adverse events in Japan. |
title_full_unstemmed |
A prospective stratified case-cohort study on statins and multiple adverse events in Japan. |
title_sort |
prospective stratified case-cohort study on statins and multiple adverse events in japan. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
PURPOSE: To assess the association between statins and diverse adverse events in Japanese population. METHODS: New users of statin who started statin after 6-month period of non-use were identified in 68 hospitals between January 2008 and July 2010. In addition to the random sample subcohort, we selected additional subcohort members to make the stratified sample subcohort have at least one patient in all subgroups stratified by each combination of statin and hospital. By abstraction from medical records, detailed information was obtained for all potential cases and pre-selected subcohort members. The event review committee consisting of 3 specialists judged whether possible cases met the definition of one of the adverse events of interest, and for adjudicated cases the committee further judged whether statin was a certain, probable or possible cause of the occurrence of the event. Adjusted for covariates including age, gender, status of "switcher", use of high daily dose and comorbidities at baseline, hazard ratio (HR) was estimated by the Cox proportional hazards model with Barlow's weighting method. Data were also analyzed by the method proposed by Breslow in 2009. RESULTS: A total of 6,877 new users of a statin were identified (median age: 66 years; males: 52%). The hazard ratios of increase in serum creatinine for atorvastatin and fluvastatin have wide confidence intervals, but both of the point estimates were around 2.5. Estimates of hazard ratios by the method of Barlow (1999) were similar to those by the method of Breslow (2009). CONCLUSIONS: Use of statin was not associated with a significant increased risk for renal, liver and muscle events. However, the hazard ratio of increase in serum creatinine tended to be high with atorvastatin and fluvastatin to require further studies. |
url |
http://europepmc.org/articles/PMC4014577?pdf=render |
work_keys_str_mv |
AT nobuhiroooba aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT tsugumichisato aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT akirawakana aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT takaoorii aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT masakikitamura aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT akirakokan aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT hideakikurata aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT yoshihiroshimodozono aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT kenichimatsui aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT hiroshiyoshida aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT takuhiroyamaguchi aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT shigerukageyama aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT kiyoshikubota aprospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT nobuhiroooba prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT tsugumichisato prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT akirawakana prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT takaoorii prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT masakikitamura prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT akirakokan prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT hideakikurata prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT yoshihiroshimodozono prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT kenichimatsui prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT hiroshiyoshida prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT takuhiroyamaguchi prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT shigerukageyama prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan AT kiyoshikubota prospectivestratifiedcasecohortstudyonstatinsandmultipleadverseeventsinjapan |
_version_ |
1725104643042705408 |